127 related articles for article (PubMed ID: 7533131)
1. Three cases of extrapulmonary small cell carcinoma occurring in the prostate, stomach, and pancreas.
Morikawa T; Kobayashi S; Yamadori I; Okino T; Hirakawa E; Kurose A; Ohmori M; Kobayashi M
Indian J Cancer; 1994 Dec; 31(4):268-73. PubMed ID: 7533131
[TBL] [Abstract][Full Text] [Related]
2. Small cell carcinoma of the prostate. A case report.
Morikawa T; Kobayashi S; Yamadori I; Okino T; Ohmori M; Kurose M
Int Urol Nephrol; 1993; 25(4):379-84. PubMed ID: 8276566
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
4. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
5. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.
Mark HF; Samy M; Santoro K; Mark S; Feldman D
Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455
[TBL] [Abstract][Full Text] [Related]
8. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
9. [Extrapulmonary small-cell carcinoma - a rarity with important therapeutic consequences].
Joss R; Jungi WF; Kapanci Y; Cavalli F
Schweiz Med Wochenschr; 1984 Feb; 114(5):161-6. PubMed ID: 6322292
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
11. [Small cell prostatic carcinoma. Presentation of diagnosis, therapy and prognosis based on a case report].
Munker R; Schalhorn A
Fortschr Med; 1994 Nov; 112(33):473-5. PubMed ID: 7843670
[TBL] [Abstract][Full Text] [Related]
12. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
13. Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
Ono J; Sakamoto H; Sakoda K; Yagi Y; Hagio S; Sato E; Katsuki T
Int Surg; 1984; 69(4):361-4. PubMed ID: 6084650
[TBL] [Abstract][Full Text] [Related]
14. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-pathological study of solid poorly differentiated carcinoma of the stomach].
Maruyama M; Kitamura M; Arai K; Yoshikawa T; Kosaki G; Takizawa T; Koike M
Gan No Rinsho; 1989 Jul; 35(8):905-11. PubMed ID: 2473227
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
18. [Multiple carcinomas as sign of carcinoma disease].
Bauer E
Monatsschr Ohrenheilkd Laryngorhinol; 1966 Nov; 100(11):507-10. PubMed ID: 16114376
[No Abstract] [Full Text] [Related]
19. Pure small-cell carcinoma of the prostate with fatal liver metastasis.
Bleichner JC; Chun B; Klappenbach RS
Arch Pathol Lab Med; 1986 Nov; 110(11):1041-4. PubMed ID: 3022668
[TBL] [Abstract][Full Text] [Related]
20. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
